No abstract available
Keywords:
Anti-VEGF; Macular degeneration; Neovascular; Quality of life; Retina.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / administration & dosage*
-
Female
-
Humans
-
Intravitreal Injections
-
Male
-
Ranibizumab / administration & dosage*
-
Receptors, Vascular Endothelial Growth Factor / administration & dosage*
-
Recombinant Fusion Proteins / administration & dosage*
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity*
-
Wet Macular Degeneration / diagnosis*
-
Wet Macular Degeneration / physiopathology
Substances
-
Angiogenesis Inhibitors
-
Recombinant Fusion Proteins
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Receptors, Vascular Endothelial Growth Factor
-
Ranibizumab